{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:15:00Z","timestamp":1788488100495,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10RR025141-01"],"award-info":[{"award-number":["1S10RR025141-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000445"],"award-info":[{"award-number":["UL1TR000445"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK134575"],"award-info":[{"award-number":["R01DK134575"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00 CA215360"],"award-info":[{"award-number":["R00 CA215360"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["1S10RR025141-01"],"award-info":[{"award-number":["1S10RR025141-01"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["UL1TR000445"],"award-info":[{"award-number":["UL1TR000445"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["825-MS-DI-33848"],"award-info":[{"award-number":["825-MS-DI-33848"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX005399-01A1"],"award-info":[{"award-number":["I01 BX005399-01A1"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["17SFRN33520017"],"award-info":[{"award-number":["17SFRN33520017"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00011\/4"],"award-info":[{"award-number":["MC_UU_00011\/4"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_20059"],"award-info":[{"award-number":["MC_PC_20059"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ebiom.2023.104674","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T11:55:05Z","timestamp":1688212505000},"page":"104674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2866-3562","authenticated-orcid":false,"given":"Megan M.","family":"Shuey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Keaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil K.","family":"Khankari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Breeyear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venexia M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent R.","family":"Heberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Reaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoa L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-2127","authenticated-orcid":false,"given":"Julie A.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijana","family":"Vujkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-6119","authenticated-orcid":false,"given":"Todd L.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2023.104674_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104674_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2337\/cd20-as01","article-title":"Standards of medical care in diabetes-2020 abridged for primary care providers","volume":"38","year":"2020","journal-title":"Clin Diabetes"},{"issue":"6865","key":"10.1016\/j.ebiom.2023.104674_bib3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"9785","key":"10.1016\/j.ebiom.2023.104674_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104674_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00125-019-05039-w","article-title":"2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European association for the Study of Diabetes (EASD)","volume":"63","author":"Buse","year":"2020","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104674_bib6","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104674_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00125-014-3460-0","article-title":"Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"58","author":"Inzucchi","year":"2015","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104674_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00125-008-1157-y","article-title":"Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"52","author":"Nathan","year":"2009","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104674_bib9","first-page":"262","article-title":"Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry","volume":"11","author":"Karter","year":"2005","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104674_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpsychores.2013.11.003","article-title":"Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes","volume":"76","author":"de Vries","year":"2014","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.ebiom.2023.104674_bib11","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2147\/PPA.S106821","article-title":"Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors","volume":"10","author":"Polonsky","year":"2016","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104674_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/dom.12449","article-title":"Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials","volume":"17","author":"Kautzky-Willer","year":"2015","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104674_bib13","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz072","article-title":"Efficacy and safety of semaglutide for type 2 diabetes by race and ethnicity: a post hoc analysis of the sustain trials","volume":"105","author":"DeSouza","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ebiom.2023.104674_bib14","article-title":"Thyroid disorders and diabetes mellitus","volume":"2011","author":"Hage","year":"2011","journal-title":"J\u00a0Thyroid Res"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104674_bib15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ebiom.2023.104674_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fendo.2019.00155","article-title":"The discovery and development of liraglutide and semaglutide","volume":"10","author":"Knudsen","year":"2019","journal-title":"Front Endocrinol"},{"issue":"21","key":"10.1016\/j.ebiom.2023.104674_bib17","first-page":"2099","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.ebiom.2023.104674_bib18","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104674_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd2005","article-title":"Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy","volume":"5","author":"Grundy","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104674_bib20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ebiom.2023.104674_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2018.10.008","article-title":"The first 3500 years of aspirin history from its roots - a concise summary","volume":"113","author":"Montinari","year":"2019","journal-title":"Vascul Pharmacol"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104674_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial","volume":"152","author":"Goldfine","year":"2010","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104674_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"383","key":"10.1016\/j.ebiom.2023.104674_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development","volume":"9","author":"Finan","year":"2017","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104674_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrg1828","article-title":"Human monogenic disorders - a source of novel drug targets","volume":"7","author":"Brinkman","year":"2006","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104674_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt.2151","article-title":"Use of genome-wide association studies for drug repositioning","volume":"30","author":"Sanseau","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104674_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molmed.2011.11.004","article-title":"Can medical genetics and evolutionary biology inspire drug target identification?","volume":"18","author":"Wang","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ebiom.2023.104674_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/2398212818812629","article-title":"Psychopharmacology: from serendipitous discoveries to rationale design, but what next?","volume":"2","author":"Robinson","year":"2018","journal-title":"Brain Neurosci Adv"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104674_bib29","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/ije\/dyx207","article-title":"Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities","volume":"46","author":"Walker","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104674_bib30","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","article-title":"Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis","volume":"52","author":"Vujkovic","year":"2020","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104674_bib31","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ajhg.2017.05.004","article-title":"Genetic-variation-driven gene-expression changes highlight genes with important functions for kidney disease","volume":"100","author":"Ko","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104674_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.molmet.2016.01.002","article-title":"Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes","volume":"5","author":"Ackermann","year":"2016","journal-title":"Mol Metab"},{"issue":"Database issue","key":"10.1016\/j.ebiom.2023.104674_bib33","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104674_bib34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nmeth.2689","article-title":"DGIdb: mining the druggable genome","volume":"10","author":"Griffith","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/j.ebiom.2023.104674_bib36","series-title":"Health services research and development:VA informatics and computing infrastructure","year":"2020"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104674_bib37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/clpt.2008.89","article-title":"Development of a large-scale de-identified DNA biobank to enable personalized medicine","volume":"84","author":"Roden","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104674_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1197\/jamia.M3378","article-title":"MedEx: a medication information extraction system for clinical narratives","volume":"17","author":"Xu","year":"2010","journal-title":"J\u00a0Am Med Inform Assoc"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104674_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033100","article-title":"Retrospective cohort study to characterise the blood pressure response to spironolactone in patients with apparent therapy-resistant hypertension using electronic medical record data","volume":"10","author":"Shuey","year":"2020","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104674_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/amiajnl-2011-000208","article-title":"Facilitating pharmacogenetic studies using electronic health records and natural-language processing: a case study of warfarin","volume":"18","author":"Xu","year":"2011","journal-title":"J\u00a0Am Med Inform Assoc"},{"key":"10.1016\/j.ebiom.2023.104674_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104038","article-title":"Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management","volume":"80","author":"Khankari","year":"2022","journal-title":"eBioMedicine"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104674_bib42","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ng.3913","article-title":"Association analyses based on false discovery rate implicate new loci for coronary artery disease","volume":"49","author":"Nelson","year":"2017","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104674_bib43","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41588-018-0171-3","article-title":"Biobank-driven genomic discovery yields new insight into atrial fibrillation biology","volume":"50","author":"Nielsen","year":"2018","journal-title":"Nat Genet"},{"issue":"15","key":"10.1016\/j.ebiom.2023.104674_bib44","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1093\/hmg\/ddw181","article-title":"Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder","volume":"25","author":"Hou","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104674_bib45","first-page":"1121","article-title":"A\u00a0comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104674_bib46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCULATIONAHA.118.035774","article-title":"Phenotypic refinement of heart failure in a national biobank facilitates genetic discovery","volume":"139","author":"Aragam","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104674_bib47","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1038\/s41467-018-07524-z","article-title":"Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies","volume":"9","year":"2018","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104674_bib48","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","article-title":"Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies","volume":"50","author":"Zhou","year":"2018","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104674_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008164","article-title":"Genome-wide association study of multisite chronic pain in UK Biobank","volume":"15","author":"Johnston","year":"2019","journal-title":"PLoS Genet"},{"issue":"7488","key":"10.1016\/j.ebiom.2023.104674_bib50","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104674_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41588-018-0303-9","article-title":"Trans-ethnic association study of blood pressure determinants in over 750,000 individuals","volume":"51","author":"Giri","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2023.104674_bib52","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104674_bib53","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104674_bib54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects","volume":"181","author":"Burgess","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104674_bib55","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41588-018-0100-5","article-title":"Genome-wide association meta-analysis of individuals of European ancestry identifies new loci explaining a substantial fraction of hair color variation and heritability","volume":"50","author":"Hysi","year":"2018","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104674_bib56","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/ije\/dyaa288","article-title":"The use of negative control outcomes in Mendelian randomization to detect potential population stratification","volume":"50","author":"Sanderson","year":"2021","journal-title":"Int J Epidemiol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423002396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423002396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:36:32Z","timestamp":1778873792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423002396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":55,"alternative-id":["S2352396423002396"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104674","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.12.14.22283414","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104674"}}